ArticleGastroenterology research and practice2018

Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway.

Ning Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.